In the second half of 2016, there was an increase in the number of birth defects potentially related to Zika virus infection.
TAK-426, and investigational drug for Zika virus, has been granted Fast Track desgination by the FDA.
The HCV treatment, sofosbuvir was found to be effective in treating the Zika virus.
Infection with the Zika virus may increase the risk for development of Guillain-Barré syndrome.
The test is not designed to diagnose an individual's infection, however.
The increased incidence of microcephaly was caused by a single mutation in the Zika virus.
Rates of neurologic complications increased in the months after the Zika virus outbreak in Brazil.
The Zika virus thrives in pregnant women because of their already dampened immune system.
Colleagues analyzed results of tissue testing for pregnancy-related Zika infection in all 50 states and Washington, D.C.
Surveillance also spotted an increase in mosquitoes that transmit dengue virus and chikungunya virus.
Zika-related birth defects might occur following Zika infection during any trimester of pregnancy.
The finding isn't overly surprising since the types of brain abnormalities seen in Zika-affected newborns have been linked to seizures and epilepsy in the past.
The threat of a zika virus outbreak is still significant in the US, especially in southern states like Texas, Florida, and Georgia.
There was an apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly.
The CDC report only accounts for physical birth defects, as researchers note that the full scope of developmental defects has yet to be recorded.
Nearly 47% of pregnancies in women with confirmed Zika virus has adverse outcomes.
Those with postnatal etiology showed worse developmental deficits across all domains.
The researchers were able to isolate Zika from the semen sample and obtain the first genome sequence of the virus.
Similar brain abnormalities are seen in confirmed and presumed cases of congenital Zika infection.
The symptoms presented during the acute infectious phase.
Testing of the compounds will take at least 1 to 2 years.
The update follows the previous clinical guidance released in February.
Researchers are hopeful that the discovery will help prevent microcephaly in the future.
Zika virus RNA was detected up to 46 days after symptom onset.
All previously reported cases of sexually transmitted Zika virus infection have been spread from men to their sex partners.
Screening criteria may need to be revised in order to detect congenital syndrome in all affected infants.
To date, 4 infants have been born with Zika-related microcephaly in the US.
Trials in monkeys and humans are the next step.
Colombian study found no cases of microcephaly when infection occurred in 3rd trimester of pregnancy.
Sexual transmission of the virus may be more common than thought.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies